Viewing Study NCT02071368


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2025-12-24 @ 5:32 PM
Study NCT ID: NCT02071368
Status: COMPLETED
Last Update Posted: 2014-07-01
First Post: 2014-02-24
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants
Sponsor: Janssen Research & Development, LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-02
Start Date Type: None
Primary Completion Date: 2014-05
Primary Completion Date Type: ACTUAL
Completion Date: 2014-05
Completion Date Type: ACTUAL
First Submit Date: 2014-02-24
First Submit QC Date: None
Study First Post Date: 2014-02-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-06-30
Last Update Post Date: 2014-07-01
Last Update Post Date Type: ESTIMATED